Remove 2008 Remove Diabetes Remove Drug Development
article thumbnail

Is India capable of ensuring equitable access to biopharmaceuticals?

Express Pharma

According to the World Health Organisation (WHO), an estimated two billion people across the world do not have access to essential medicines for life threatening diseases like cancer, AIDS and even autoimmune diseases like Type 1 diabetes.

article thumbnail

The Witty Answer to GSK’s Future

Pharmaceutical Technology

Andrew Witty took the helm of pharmaceutical giant GlaxoSmithKline in May 2008. PT: Given recent problems with a safety scare over diabetes drug Avandia and GSK’s guidance for a fall in 2008 earnings, what do you envisage Witty’s top or first priorities will be in the new job?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Taming cardiovascular risk: the promise of LDL cholesterol lowering therapeutics

European Pharmaceutical Review

Obesity, metabolic syndrome, diabetes epidemic is global, so that aggravates cardiovascular risk… we are seeing a marked acceleration of heart disease deaths, and we need to find new therapies to make a difference. What are the top three trends impacting the cardiovascular drug development space today?

article thumbnail

Top 20 IPOs in Healthcare by Total Fund Value

PharmaShots

Shots: Immutable capital demands and high-spending drug development plans are the most common drivers in encouraging fully-fledged private healthcare companies to go public. Founded Year: 2008 No. It has also been granted RPD and FTD designation in the US and has obtained Orphan Drug Designation in both US and Europe.